Pengaruh Bevacizumab Intravitreal terhadap Best Corrected Visual Acuity dan Central Macular Thickness pada Diabetic Macular Edema
Diabetic Macular Edema (DME) adalah penyebab utama kebutaan pada populasi diabetes. Salah satu patogenesis pada DME adalah karena peningkatan ekspresi VEGF. Bevacizumab adalah anti-VEGF yang dapat meningkatkan Best Corrected Visual Acuity (BCVA) dan mengurangi Central Macular Thickness (CMT) pada pa...
Saved in:
Main Authors: | Arini Ghaisa Atsari, Weni Helvinda |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine at Universitas Andalas
2020-01-01
|
Series: | Jurnal Kesehatan Andalas |
Online Access: | http://jurnal.fk.unand.ac.id/index.php/jka/article/view/1094 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Analysis of Correlative Factors of Visual Acuity with Intravitreal Conbercept Injection in Macular Edema Associated with Branch Retinal Vein Occlusion
by: Wenjuan Luo, et al.
Published: (2018-01-01) -
Bevacizumab Injection in Patients with Age-Related Macular Degeneration Associated with Poor Initial Visual Acuity
by: Leila El Matri, et al.
Published: (2012-01-01) -
Association between Visual Acuity and Retinal Layer Metrics in Diabetics with and without Macular Edema
by: LakshmiPriya Rangaraju, et al.
Published: (2018-01-01) -
Intra-operative Intravitreal Bevacizumab For Patients With Diabetic Macular Edema Undergoing Phacoemulsification with Foldable IOL Implantation
by: Haider Ali Chaudhry, et al.
Published: (2024-06-01) -
Intravitreal Therapy for Diabetic Macular Edema: An Update
by: Claudio Furino, et al.
Published: (2021-01-01)